Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente.

Black S, Lieu TA, Ray GT, Capra A, Shinefield HR

Open source

DOI
10.1016/s0264-410x(00)00284-x
Published
2000 Dec 8
Container
Vaccine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0264-410x-00-00284-x,
  title = {Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente.},
  author = {Black S and Lieu TA and Ray GT and Capra A and Shinefield HR},
  year = {2000},
  journal = {Vaccine},
  doi = {10.1016/s0264-410x(00)00284-x},
  url = {https://doi.org/10.1016/s0264-410x(00)00284-x}
}

RIS

TY  - JOUR
TI  - Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente.
AU  - Black S
AU  - Lieu TA
AU  - Ray GT
AU  - Capra A
AU  - Shinefield HR
PY  - 2000
JO  - Vaccine
DO  - 10.1016/s0264-410x(00)00284-x
UR  - https://doi.org/10.1016/s0264-410x(00)00284-x
ER  - 

APA

S, B., TA, L., GT, R., A, C., & HR, S. (2000). Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente.. Vaccine. https://doi.org/10.1016/s0264-410x(00)00284-x

Source records